ArticleMedicine2019

The efficacy and safety of Kyung-Ok-Ko on cancer-related fatigue in lung cancer patients: Study protocol for a randomized, patients-assessor blind, placebo-controlled, parallel-group, single-center trial.

Kwan-Il Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.